アレルギー性鼻炎の世界市場レポート 2024年

アレルギー性鼻炎市場規模は近年着実に成長しています。2023年の145億7,000万米ドルから2024年には152億2,000万米ドルへとCAGR4.5％で拡大します。実績期間の成長は、アレルゲンへの暴露、環境の変化、国民の意識、汚染の増加、アレルギー性鼻炎の研究開発、可処分所得の増加などに起因しています。

アレルギー性鼻炎市場の成長は、大気汚染レベルの上昇と気候変動の影響によって促進されています。地球の大気中に有害物質が存在する大気汚染は、人間の健康と環境の両方に重大なリスクをもたらします。気候パターンの長期的な変化を特徴とする気候変動は、この問題をさらに悪化させています。注目すべきは、大気汚染がアレルギー性鼻炎の蔓延と悪化の一因となっていることがますます認識されるようになり、大気の質と呼吸器の健康との間に複雑な関係があることが浮き彫りになっていることです。例えば、2022年9月、世界銀行は、大気汚染による健康被害は年間約8兆1,000億米ドルに上り、世界GDPの6.1%に相当すると試算しました。その結果、高レベルの大気汚染と気候変動の影響がアレルギー性鼻炎市場の成長を促進しています。

2023年のアレルギー性鼻炎市場で最大の地域は北米です。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。アレルギー性鼻炎レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のアレルギー性鼻炎市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 季節性アレルギー性鼻炎
• 通年性アレルギー性鼻炎
• 職業性アレルギー性鼻炎
• 世界のアレルギー性鼻炎市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 抗ヒスタミン薬
• コルチコステロイド
• 免疫療法
• 鼻詰まり除去剤
• その他
• 世界のアレルギー性鼻炎市場、検査別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 皮膚テスト
• IgE放射性アレルギー吸着剤（RAST）検査
• 全血球計算
• 世界のアレルギー性鼻炎市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口
• 経鼻
• その他
• 世界のアレルギー性鼻炎市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院薬局
• 小売薬局
• オンラインストア

第7章 地域および国の分析

• 世界のアレルギー性鼻炎市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界のアレルギー性鼻炎市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アレルギー性鼻炎市場の競合情勢
• アレルギー性鼻炎市場の企業プロファイル
  • Merck and Co. Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi-Aventis LLC.
  • AstraZeneca PLC

第31章 その他の主要および革新的な企業

• GlaxoSmithKline plc.
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• UCB S.A.
• Sun Pharmaceutical Industries Limited
• Menarini Group
• Perrigo Company plc
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals PLC
• Cipla Limited
• Endo Pharmaceuticals Inc.
• Zydus Lifesciences Ltd.
• Lupin Limited

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

“Allergic Rhinitis Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on allergic rhinitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for allergic rhinitis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The allergic rhinitis market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis; Occupational Allergic Rhinitis
• 2) By Treatment: Antihistamines; Corticosteroids; Immunotherapy; Decongestants; Other Treatments
• 3) By Test: Skin Test; IgE Radioallergosorbent (RAST) Test; Complete Blood Count
• 4) By Route Of Administration: Oral; Nasal; Other Route Of Administration
• 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Stores
• Companies Mentioned: Merck and Co. Inc.; Bayer AG; Novartis AG; Sanofi-Aventis LLC.; AstraZeneca PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Allergic rhinitis is a condition characterized by an allergic response that triggers nasal inflammation due to allergens like pollen, dust, mold, or pet dander. This allergic reaction leads to symptoms such as sneezing, nasal congestion, an itchy nose, and a sore throat. The management of allergic rhinitis involves the use of a range of allergy medications available in different dosage forms to alleviate these bothersome symptoms.

Allergic rhinitis can be categorized into several types, including seasonal allergic rhinitis (SAR), perennial allergic rhinitis, and occupational allergic rhinitis. SAR is characterized by the rapid onset and resolution of symptoms, often associated with allergens like pollen. The treatments for allergic rhinitis encompass various options such as antihistamines, corticosteroids, immunotherapy, and decongestants. Diagnosis and evaluation may involve different tests like skin tests, IgE radioallergosorbent tests, and complete blood counts. These treatments are administered through various routes, including oral and nasal administration. Moreover, they are accessible through diverse distribution channels such as hospital pharmacies, retail pharmacies, and online stores.

The allergic rhinitis market research report is one of a series of new reports from The Business Research Company that provides allergic rhinitis market statistics, including allergic rhinitis industry global market size, regional shares, competitors with an allergic rhinitis market share, detailed allergic rhinitis market segments, market trends and opportunities and any further data you may need to thrive in the allergic rhinitis industry. This allergic rhinitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The allergic rhinitis market size has grown steadily in recent years. It will grow from $14.57 billion in 2023 to $15.22 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to allergen exposure, environmental changes, public awareness, incresing pollution, research and developments on allergic rhinitis, rising disposable incomes.

The allergic rhinitis market size is expected to see steady growth in the next few years. It will grow to $17.62 billion in 2028 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to demand for preventive treatments, aging population, urbanization, health care spending. Major trends in the forecast period include biologics and monoclonal antibodies, digital health solutions, allergen avoidance strategies, pediatric allergic rhinitis, allergen detection technology.

The growth in the allergic rhinitis market is being fueled by elevated levels of air pollution and the effects of climate change. Air pollution, which involves the presence of harmful substances in the Earth's atmosphere, poses a significant risk to both human health and the environment. Climate change, characterized by long-term shifts in climate patterns, further exacerbates this issue. Notably, air pollution has been increasingly recognized for its role in contributing to the prevalence and worsening of allergic rhinitis, underscoring the intricate connection between air quality and respiratory well-being. For instance, in September 2022, the World Bank estimated that the health damage caused by air pollution would result in annual costs of approximately $8.1 trillion, equivalent to 6.1% of the global GDP. Consequently, the high levels of air pollution and the impact of climate change are driving the growth of the allergic rhinitis market.

The growing adoption of corticosteroid treatment in the management of allergic rhinitis is anticipated to be a key driver for the expansion of the allergic rhinitis market. Corticosteroid treatment, commonly known as steroid treatment, encompasses the use of medications called corticosteroids, which have proven effective in reducing inflammation in the nasal passages and alleviating symptoms associated with this condition. For instance, in April 2022 by JAMA Network, a publication by the American Medical Association based in the United States, there has been an upward trend in the utilization of corticosteroids. Their usage has increased significantly, rising from 2.2% in April 2020 to 21.1% in August 2021 for Medicare, and from 2.2% to 13.8% in July 2021 for Sentinel. Consequently, the surge in corticosteroid treatment for allergic rhinitis is a driving force behind the growth of the allergic rhinitis market.

The presence of side effects related to therapies for allergic rhinitis stands as a major impediment to the expansion of the market. Commonly observed adverse effects in the treatment of allergic rhinitis encompass nosebleeds, debilitating headaches, discomfort in the eyes and nose, urinary flow issues in men, and elevated blood pressure in individuals with hypertension. This situation is exacerbated by the increasing trend of self-medication without professional medical guidance. For example, in July 2023, according to a study conducted by the National Library of Medicine, a US-based medical library, challenges in managing airway compromise associated with allergic rhinitis revealed that 27% of patients using first-generation antihistamines experienced sedation, in contrast to 5% of patients using second-generation antihistamines. Hence, the adverse effects linked to allergic rhinitis treatments represent a significant constraint on the growth of the allergic rhinitis market.

Prominent players within the allergic rhinitis market are actively engaged in the development of cutting-edge medications to maintain their market presence. For instance, in August 2022, Hikma Pharmaceuticals PLC, a pharmaceutical company based in the UK, and Glenmark Specialty S.A., a pharmaceutical company headquartered in Switzerland, received approval from the United States Food and Drug Administration (FDA), a federal agency based in the US, for their product known as Ryaltris. Ryaltris represents the first fixed-dose combination medication designed to alleviate both nasal and ocular symptoms of seasonal allergic rhinitis. It is conveniently administered as a nasal spray for adult and pediatric patients aged 12 and above. Notably, the relief from nasal symptoms begins within 15 minutes of the initial dose.

In January 2022, Glenmark Specialty S.A., a pharmaceutical company headquartered in Switzerland, established a partnership with Lotus International Pte. Ltd., a pharmaceutical company based in Singapore. Through this collaboration, Glenmark is set to introduce Ryaltris, an innovative nasal spray designed for allergic rhinitis treatment, into the markets of Singapore, Hong Kong, and Vietnam. Under this arrangement, Glenmark will be responsible for the manufacturing and supply of Ryaltris, while Lotus will oversee the commercialization of Ryaltris in these regions.

Major players in the allergic rhinitis market are Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Limited, Menarini Group, Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Endo Pharmaceuticals Inc., Zydus Lifesciences Ltd., Lupin Limited, Glenmark Pharma Ltd., Almirall S.A., Kyowa Kirin Co. Ltd., Hanmi Pharmaceutical Co. Ltd., Akorn Inc.

North America was the largest region in the allergic rhinitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the allergic rhinitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The allergic rhinitis market consists of revenues earned by entities by providing treatments such as alternative therapies, surgeries and lifestyle modifications. The market value includes the value of related goods sold by the service provider or included within the service offering. The allergic rhinitis market also includes sales of allergy pills and injections that are used for the treatment of the disease. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Allergic Rhinitis Market Characteristics

3. Allergic Rhinitis Market Trends And Strategies

4. Allergic Rhinitis Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Allergic Rhinitis Market Size and Growth

• 5.1. Global Allergic Rhinitis Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Allergic Rhinitis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Allergic Rhinitis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Allergic Rhinitis Market Segmentation

• 6.1. Global Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Seasonal Allergic Rhinitis
• Perennial Allergic Rhinitis
• Occupational Allergic Rhinitis
• 6.2. Global Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Antihistamines
• Corticosteroids
• Immunotherapy
• Decongestants
• Other Treatments
• 6.3. Global Allergic Rhinitis Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Skin Test
• IgE Radioallergosorbent (RAST) Test
• Complete Blood Count
• 6.4. Global Allergic Rhinitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Nasal
• Other Route Of Administration
• 6.5. Global Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores

7. Allergic Rhinitis Market Regional And Country Analysis

• 7.1. Global Allergic Rhinitis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Allergic Rhinitis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Allergic Rhinitis Market

• 8.1. Asia-Pacific Allergic Rhinitis Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Allergic Rhinitis Market

• 9.1. China Allergic Rhinitis Market Overview
• 9.2. China Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Allergic Rhinitis Market

• 10.1. India Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Allergic Rhinitis Market

• 11.1. Japan Allergic Rhinitis Market Overview
• 11.2. Japan Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Allergic Rhinitis Market

• 12.1. Australia Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Allergic Rhinitis Market

• 13.1. Indonesia Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Allergic Rhinitis Market

• 14.1. South Korea Allergic Rhinitis Market Overview
• 14.2. South Korea Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Allergic Rhinitis Market

• 15.1. Western Europe Allergic Rhinitis Market Overview
• 15.2. Western Europe Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Allergic Rhinitis Market

• 16.1. UK Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Allergic Rhinitis Market

• 17.1. Germany Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Allergic Rhinitis Market

• 18.1. France Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Allergic Rhinitis Market

• 19.1. Italy Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Allergic Rhinitis Market

• 20.1. Spain Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Allergic Rhinitis Market

• 21.1. Eastern Europe Allergic Rhinitis Market Overview
• 21.2. Eastern Europe Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Allergic Rhinitis Market

• 22.1. Russia Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Allergic Rhinitis Market

• 23.1. North America Allergic Rhinitis Market Overview
• 23.2. North America Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Allergic Rhinitis Market

• 24.1. USA Allergic Rhinitis Market Overview
• 24.2. USA Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Allergic Rhinitis Market

• 25.1. Canada Allergic Rhinitis Market Overview
• 25.2. Canada Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Allergic Rhinitis Market

• 26.1. South America Allergic Rhinitis Market Overview
• 26.2. South America Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Allergic Rhinitis Market

• 27.1. Brazil Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Allergic Rhinitis Market

• 28.1. Middle East Allergic Rhinitis Market Overview
• 28.2. Middle East Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Allergic Rhinitis Market

• 29.1. Africa Allergic Rhinitis Market Overview
• 29.2. Africa Allergic Rhinitis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Allergic Rhinitis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Allergic Rhinitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Allergic Rhinitis Market Competitive Landscape And Company Profiles

• 30.1. Allergic Rhinitis Market Competitive Landscape
• 30.2. Allergic Rhinitis Market Company Profiles
  • 30.2.1. Merck and Co. Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bayer AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Novartis AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Sanofi-Aventis LLC.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. AstraZeneca PLC
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Allergic Rhinitis Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline plc.
• 31.2. Boehringer Ingelheim International GmbH
• 31.3. Viatris Inc.
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Regeneron Pharmaceuticals Inc.
• 31.6. UCB S.A.
• 31.7. Sun Pharmaceutical Industries Limited
• 31.8. Menarini Group
• 31.9. Perrigo Company plc
• 31.10. Dr. Reddy's Laboratories Ltd.
• 31.11. Hikma Pharmaceuticals PLC
• 31.12. Cipla Limited
• 31.13. Endo Pharmaceuticals Inc.
• 31.14. Zydus Lifesciences Ltd.
• 31.15. Lupin Limited

32. Global Allergic Rhinitis Market Competitive Benchmarking

33. Global Allergic Rhinitis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Allergic Rhinitis Market

35. Allergic Rhinitis Market Future Outlook and Potential Analysis

• 35.1 Allergic Rhinitis Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Allergic Rhinitis Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Allergic Rhinitis Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer